Page 1431 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

25. Uchino S, Bellomo R, Ronco C. Intermittent versus continous 43. Overberger P, Pesacreta M, Palevsky PM. Management of renal
renal replacement therapy in the ICU: impact on electrolyte and replacement therapy in acute kidney injury: a survey of prac-
acid-base balance. Intensive Care Med. 2001;27:1037-1043. titoner prescribing practices. Clin J Am Soc Nephrol. 2007;2:
26. Hilton PJ, Taylor J, Forni LG, Treacher DF. Bicarbonate-based 623-630.
haemofiltration in the management acute renal failure with 44. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the out-
lactic acidosis. Q J Med. 1998;91:279-283. come of acute renal failure. N Engl J Med. 2002;346:305-310.
27. Levraut J, Ciebera J, Jambou P, et al. Effect of continuous veno- 45. Ronco C, Bellomo R, Homel P, et al. Effects of different doses
venous hemofiltration with dialysis on lactate clearance in criti- of in continuous venovenous hemofiltration on outcomes of
cally ill patients. Crit Care Med. 1997;25(1):58-62. acute renal failure: a prospective, randomized trial. Lancet.
28. Ratanarat R, Brendolan A, Volker G, et al. Phosphate kinetics 2000;355:26-30.
during different dialysis modalities. Blood Purif. 2005;23:83-90. 46. Saudan P, Niederberger M, De Seigneux S, et al. Adding a
29. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin dialysis dose to continuous hemofiltration increases survival in
levels correlate with survival in patients with sepsis syndrome. patients with acute renal failure. Kidney Int. 2006;70:1312-1317.
Ann Intern Med. 1993;119:771-778. 47. Tolwani AJ, Campbell RC, Stofan BS, et al. Standard versus
30. Simmons EM, Himmelfarb J, Sezer MT, et al. Plasma cytokine high-dose CVVHDF for ICU-related acute renal failure. J Am
levels predict mortality in patients with acute renal failure. Soc Nephrol. 2008;19:1233-1238.
Kidney Int. 2004;65:1357-1365. 48. VA/NIH Acute Renal Failure Trial Network. Intensity of renal
31. Heering P, Morgera S, Schmitz FJ, et al. Cytokine removal support in critically ill patients with acute kidney injury. N Engl
and cardiovascular hemodynamics in septic patients with J Med. 2008;359:7-20.
continuous venovenous hemofiltration. Intensive Care Med. 49. The RENAL Replacement Study Investigators. Intensity of
1997;23:288-296. continuous renal replacement therapy in critically-ill patients.
32. De Vriese AN, Colardyn FA, Philippe JJ, et al. Cytokine removal N Engl J Med. 2009;361:1627-1638.
during continuous hemofiltration in septic patients. J Am Soc 50. Jun M, Heerspink HJL, Ninomiya T, et al. Intensities of renal
Nephrol. 1999;10:846-853. replacement therapy in acute kidney injury: a systematic review
33. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B. The and meta-analysis. Clin J Am Soc Nephrol. 2010;(6):956-963.
effect of intensive plasma water exchange by hemofiltration on 51. Van Wert RJ, Scales DC, Friedrich JO, Wald R, Adhikari NK.
hemodynamics and soluble mediators in canine endotoxemia. High-dose renal replacment therapy for acute kidney
Am J Respir Crit Care Med. 2000;161:1429-1436. injury: systematic review and meta-analysis. Crit Care Med.
34. Grootendorst AF, van Bommel EF, van Der HB, van Leengoed LA, 2010;38(5):1360-1369.
van Osta AL. High volume hemofiltration improves right 52. Farrell J, Gellens M. Ultrasound-guided cannulation versus
ventricular function in endotoxin-induced shock in the pig. the landmark-guided technique for acute hemodialysis access.
Intensive Care Med. 1992;18:235-240. Nephrol Dial Transplant. 1997;12:1234-1237.
35. Grootendorst AF, van Bommel EF, van Leengoed LA, et al. 53. Bansal R, Agarwal SK, Tiwari SC, Dash SC. A prospective ran-
High volume hemofiltration improves hemodynamics and domized study to compare ultrasound-guided with nonultra-
survival of pigs exposed to gut ischemia and reperfusion. sound-guided double lumen internal jugular catheter insertion
Shock. 1994;2:72-78. as a temporary hemodialysis access. Ren Fail. 2005;27:561-564.
36. Honore PM, Jamez J, Wauthier M, et al. Prospective evalu- 54. Prabhu MV, Juneja D, Gopal PB, et al. Ultrasound-guided femo-
ation of short-term, high-volume isovolemic hemofiltration ral dialysis access placement: a single-center randomized trial.
on the hemodynamic course and outcome in patients with Clin J Am Soc Nephrol. 2010;2:235-239.
incrtractable circulatory failure resulting from septic shock. Crit 55. Parienti J, Thirion M, Megarbane B, et al. Femoral vs jugular
Care Med. 2000;28:3581-3587. venous catheterization and risk of nosocomial events in adults
37. Ratanarat R, Brendolan A, Piccinni P, et al. Pulse, high-volume requiring acute renal replacement therapy: a randomized con-
hemofiltration for treatment of severe sepsis effects on hemody- trolled trial. JAMA. 2008;299:2413-2422.
namics and survival. Crit Care. 2005;9:R294-R302. 56. Parienti J, Megarbane B, Fischer M, et al. Catheter dyfunction
38. Cole L, Bellomo R, Journois D, et al. High-volume hemofiltration and dialysis performance according to vascular access among
in human septic shock. Intensive Care Med. 2001;27:978-986. 736 critically ill adults requiring renal replacement therapy: a
39. Ghani RA, Zainuddin S, Ctkong N, et al. Serum IL-6 and randomized controlled trial. Crit Care Med. 2010;38:1118-1125.
IL-1ra with sequential organ failure assessment scores in septic 57. Van de Wetering J, Westendorp RG, van der Hoeven JG, et al.
patients receiving high-volume and continuous venovenous Heparin use in continuous renal replacement procedures: the
hemofiltration. Nephrology. 2006;11:386-393. balance between filter coagulation and patient hemorrhage. J
40. Ricci Z, Ronco C, Bachetoni A, et al. Solute removal during Am Soc Nephrol. 1996;7:145-150.
continuous renal replacement therapy in critically ill patients: 58. Tolwani AJ, Willie KM. Anticoagulation for continuous renal
convection versus diffusion. Crit Care. 2006;10(2):R67. replacement therapy. Semin Dial. 2009;22:141-145.
41. Messer J, Mulcahy B, Fissell WH. Middle-molecule clearance in 59. Jeffrey RF, Khan AA, Douglas JT, Will EJ, Davison AM.
CRRT: in vitro convection, diffusion and dialyzer area. ASAIO Anticoagulation with low molecular weight heparin (Fragmin)
J. 2009;55:224-226. during continuous hemodialysis in the intensive care unit. Artif
42. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose Organs. 1993;17:717-720.
and membrane flux in maintenance hemodialysis. N Engl J Med. 60. Reeves JH, Cumming AR, Gallagher L, O’Brien JL, Santamaria JD.
2002;347(25):2010-2019. A controlled trial of low-molecular-weight heparin (dalteparin)

Section08-O-Ref.indd 2 12/10/2014 6:08:08 PM